Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Celcuity To Present at Upcoming Stifel 2025 Healthcare Conference
-
Xometry Reports Record Third Quarter 2025 Results
-
Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025
-
OnEquity Earns “Best Multi-Asset Institutional Broker – APAC” at UF AWARDS 2025
-
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
-
Abcourt Announces Arrangements for Upcoming Annual Meeting of Shareholders in Event of Canada Post Service Disruption
-
Geography Shouldn’t Determine Access to Justice: New Report Reveals Deep Inequities in Forensic Evidence Collection for Sexual Assault Survivors in Canada’s Remote and Indigenous Communities
-
Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
-
Dave Reports Third Quarter 2025 Financial Results
-
AmpliTech Group To Release Q3 – 2025 Earnings On November 14th Before Market Opening - Also Announces Investor’s Conference Call
-
Lancaster Resources Expands Footprint in James Bay with Additional Claims at Lac Iris Polymetallic Project
-
Capital City Bank Appoints Alicia Williams-Ronan Chief Retail Officer
-
Kymera Therapeutics Announces Third Quarter 2025 Financial Results and Provides a Business Update
-
Caliber Sets Date for Third Quarter 2025 Earnings Announcement & Investor Conference Call
-
Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates
-
Parex Resources Announces Third Quarter Results, Strong October 2025 Production, and Declaration of Q4 2025 Dividend
-
Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors
-
Yukon Metals Launches Digital Marketing Campaign
-
Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ
-
Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
SNDL Reports Third Quarter 2025 Financial and Operational Results
-
EDAP to Present at Jefferies Global Healthcare Conference in London
-
First Watch Restaurant Group, Inc. Reports Q3 2025 Financial Results
-
Moisson Montréal Named Among Canada’s Top 10 Most Impactful Food Banks by Charity Intelligence
-
Chicago Atlantic Real Estate Finance Announces Third Quarter 2025 Financial Results
-
Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation
-
Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates
-
Ocular Therapeutix™ Achieves Target Randomization of 555 Subjects in SOL-R
-
Secura Bio Announces Poster Presentation Highlighting Extended Follow Up Analyses from Phase 2 PRIMO Trial at the 2025 American Society of Hematology Meeting
-
Attralus To Present Phase 1/2 Data on Its Pan Amyloid Depleter at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
-
NexGold Achieves Critical Permitting Milestone; Receives Final Federal Approval for the Goldboro Gold Project
-
WeRide Announces Pricing of Global Offering
-
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical
-
White Gold Corp. Increases High-grade Gold Mineralization at Golden Saddle Intersecting 6.9 g/t Gold over 50.2 Metres in the Main Zone and Expands the High-Grade Footwall Breccia and Hanging Wall Mine
-
CervoMed Announces Alignment with FDA on Registration Path for Neflamapimod in Dementia with Lewy Bodies
-
Plug To Announce 2025 Third Quarter Results on November 10, 2025
-
Shoals Technologies Group, Inc. Reports Financial Results for Third Quarter 2025
-
Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy
-
NCPA and USC Launch First Publicly Available Tool to Identify Pharmacy Shortage Areas Across America
-
Amplify ETFs Launches the Amplify Solana 3% Monthly Option Income ETF (SOLM)
-
LGI Homes, Inc. Reports Third Quarter 2025 Results
-
Stewards Inc. Announces $10 Million Private Placement With Dolomite Foundation to Advance Digital Asset Strategy
-
MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
-
Colliers Reports Third Quarter Results
-
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
-
Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across Canada
-
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
-
Sotera Health Reports Strong Third-Quarter and Year-to-Date 2025 Results
-
Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update

